Abstract
Several parameters representing the clinical diversity of Parkinson's disease (PD), including severity, phenotypes, cognitive decline, anxiety and depression were analyzed to examine the link with interleukin-1β (IL-1β), the interleukin-1 receptor antagonist (IL-1RA), IL-6, IL-10, and tumor necrosis factor-α (TNFα) and also to determine the relationship between levels of these factors in serum and cerebrospinal fluid (CSF). Significantly elevated serum IL-1β and IL-6 and reduced IL-1RA levels were found in the PD group. In CSF and serum, inflammatory factors behaved differently, with increased CSF TNFα indicating rapid PD progression, and increased IL-1β in serum. A low level of IL-6 was associated with a longer duration of PD. Anxiety, depression, non-tremor phenotype and late-onset PD correlated with a high serum level of IL-10. The serum TNFα level was lower in PD patients with mild cognitive impairment compared to controls. Serum IL-1β, IL-6 and IL-10 levels correlated with CSF markers.
Citations
Feb 9, 2019·Phytotherapy Research : PTR·Bei CuiRongli Fu
Oct 2, 2019·Open Medicine·Nianshui Jing, Xinnan Li
Nov 9, 2019·Behavioural Pharmacology·Lais S RodriguesMarcelo M S Lima
Mar 9, 2020·Bulletin of Experimental Biology and Medicine·I V MiliukhinaS N Pchelina
Jun 19, 2019·PLoS Biology·Weihua WangShaowen Bao
May 16, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Ruwani S WijeyekoonCaroline H Williams-Gray
Mar 25, 2019·Frontiers in Neurology·Tino PrellJulian Grosskreutz
Apr 4, 2019·Frontiers in Neurology·Marie Therese Fuzzati-ArmenteroFabio Blandini
Apr 21, 2020·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·O V BelovaS N Moskvina
Jul 15, 2020·Biomolecules·Chiara PorroMaria Antonietta Panaro
Apr 26, 2020·Nature Reviews. Neurology·Eng-King TanJoseph Jankovic
Oct 21, 2020·Journal of Neural Transmission·Antonio Martin-BastidaRoberta J Ward
Oct 22, 2020·Sleep & Breathing = Schlaf & Atmung·Ferda Ilgen UsluAbdürahim Koçyiğit
Dec 17, 2020·Frontiers in Immunology·André J EsgalhadoFernando A Arosa
Dec 22, 2020·The International Journal of Neuroscience·Zamira M MuruzhevaMarina N Karpenko
Dec 30, 2020·The Journal of Biological Chemistry·Emily H ClarkThomas Briston
Jan 19, 2021·Journal of Alzheimer's Disease : JAD·Lei HuangYajia Lan
Jan 8, 2021·The Journal of Biological Chemistry·Emily H ClarkThomas Briston
Mar 18, 2021·Neurological Research·Zamira M MuruzhevaMarina N Karpenko
Mar 16, 2021·Frontiers in Neuroscience·Vidar Gundersen
Mar 31, 2021·The International Journal of Neuroscience·Dan-Dan ZhangHua Jia
Apr 16, 2021·Frontiers in Neuroscience·Yoo Jin JungNigel H Greig
Nov 14, 2020·International Journal of Molecular Sciences·Chrysoula MarogianniGeorgia Xiromerisiou
Jun 9, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Laura Muñoz-DelgadoPablo Mir
Jan 8, 2019·Journal of Agricultural and Food Chemistry·Dong-Rui ZhaoMou-Ming Zhao
Nov 28, 2020·ACS Chemical Neuroscience·Cristian Follmer
Oct 9, 2021·Seminars in Thrombosis and Hemostasis·Martin J Page, Etheresia Pretorius
Nov 13, 2021·Metabolic Brain Disease·Ali Sarbazi-Golezari, Hashem Haghdoost-Yazdi